Ginkgo Bioworks Holdings, Inc. DNA

Latest FY: 2025 Healthcare Biotechnology
Market Price $6.95
Market Cap $454.01M
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↓-25.1% YoY
$170.16M
3-Yr CAGR: -29.1%
Net Income
N/A
Net Margin: N/A
Free Cash Flow ↑53.2% YoY
-$178.72M
FCF Yield: -39.37%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
N/A
ROA: N/A

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (DNA)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2019 $54.2M $51.8M $-44.7M $-66.9M
FY 2020 $76.7M +41.5% $61.0M $-135.8M $-193.7M -189.5%
FY 2021 $313.8M +309.4% $184.1M 0.00% $-253.8M $-310.3M -60.3%
FY 2022 $477.7M +52.2% $273.5M 0.00% $-252.2M $-304.5M +1.9%
FY 2023 $251.5M -47.4% $197.4M 0.00% $-295.5M $-336.3M -10.5%
FY 2024 $227.0M -9.7% $182.5M 0.00% $-319.6M $-382.1M -13.6%
FY 2025 $170.2M -25.1% $123.2M 0.00% $-171.1M $-178.7M +53.2%
$

Valuation

Market Price $6.95
Market Cap $454.01M
Enterprise Value $286.80M
P/E Ratio N/A
P/B Ratio 0.89
FCF Yield -39.37%
Dividend Yield N/A
Shares Outstanding 65,324,500
%

Profitability & Margins

Gross Margin 72.39%
Operating Margin N/A
Net Margin N/A
Return on Equity (ROE) N/A
Return on Assets (ROA) N/A
Asset Turnover 0.15x
Revenue 3-Yr CAGR -29.11%
🛡️

Financial Health & Liquidity

Current Ratio 0.38
Cash Ratio 2.52
Debt / Equity 0.000
Debt / Assets 0.000
Cash & Equivalents $167.20M
Total Debt N/A
Book Value / Share $7.79
💧

Cash Flow Efficiency

Operating Cash Flow -$171.06M
Capital Expenditures (CapEx) $7.67M
Free Cash Flow -$178.72M
OCF / Revenue -100.53%
FCF / Revenue -105.04%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share $7.79
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2025)

Total Assets $1.12B
Total Liabilities $611.11M
Stockholders' Equity $508.59M
Current Assets $24.96M
Current Liabilities $66.46M